Category: Medications - Page 5

21 Nov

REMS Programs: Understanding FDA's Risk Evaluation and Mitigation Strategies for High-Risk Medications

REMS programs are FDA-mandated safety systems for high-risk medications. They require special training, monitoring, and controls to ensure benefits outweigh risks. Learn how they work, who they affect, and what’s changing in 2025.

20 Nov

Deficiency Letters in Generic Drug Applications: Top FDA Findings and How to Avoid Them

Learn the top FDA deficiency findings in generic drug applications and how to avoid costly delays. Key issues include dissolution methods, impurities, and bioequivalence data.

19 Nov

Generic Drug Shortages: Causes and How They Limit Patient Access

Generic drug shortages are worsening in the U.S., with 270 active shortages in 2025. Caused by low profits, foreign manufacturing, and lack of backup suppliers, they delay treatments, raise prices, and put patient safety at risk.

18 Nov

How to Read Contraindications and Warnings on Drug Labels: A Clear Guide for Patients and Caregivers

Learn how to read contraindications and warnings on drug labels to avoid dangerous side effects. Understand FDA-required sections like Boxed Warnings, contraindications, and OTC Drug Facts for safer medication use.

16 Nov

St. John’s Wort and Dangerous Drug Interactions You Need to Know

St. John’s Wort may help with mild depression, but it can dangerously reduce the effectiveness of birth control, blood thinners, HIV meds, and antidepressants. Learn the real risks and what to do instead.

14 Nov

Why Regular Eye Exams Are Critical When Using Timolol

Timolol helps control eye pressure in glaucoma, but regular eye exams are essential to catch hidden damage. Skipping check-ups risks permanent vision loss-even if you feel fine.

14 Nov

When to Report Rare Side Effects from Generic Medications

Learn when and how to report rare side effects from generic medications. Understand what counts as serious, how to submit a report to the FDA, and why your input helps improve drug safety for everyone.

12 Nov

Statins and ALS: What the Latest Science Really Shows

Statins and ALS: What the latest science shows. No proven link exists. Stopping statins for ALS concerns can be dangerous. Learn what major health agencies say and why continuing treatment is often the safest choice.

9 Nov

FDA Regulatory Authority: How the Agency Approves Generic Drugs

The FDA approves generic drugs through the ANDA process, ensuring they're as safe and effective as brand-name drugs at a fraction of the cost. Learn how bioequivalence, manufacturing standards, and regulatory oversight make generics reliable.

1 Nov

Why Monitoring Digoxin Levels Is Critical for Patient Safety

Digoxin is effective for heart failure and arrhythmias but has a narrow safety margin. Monitoring blood levels regularly prevents life-threatening toxicity, especially in older adults and those with kidney issues.